Thomas F Goss (Thomas Goss)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Breast Cancer Risk

Dna Methylation

Artificial Intelligence

Sentinel Lymph Node

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Salwa F Masud, Noah Mark, Thomas F Goss, Doug Malinowski, Stuart J Schnitt, Joseph A Sparano, Michael J Donovan
U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer. Journal of medical economics 27 (1) (2024)
Salwa F Masud, Noah Mark, Thomas F Goss, Doug Malinowski, Stuart J Schnitt, Joseph A Sparano, Michael J Donovan
U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer. Journal of medical economics (2024)
Salwa F Masud, Noah Mark, Thomas F Goss, Doug Malinowski, Stuart J Schnitt, Joseph A Sparano, Michael J Donovan
U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer. Journal of medical economics 27 (1) (2024)
Salwa F Masud, Noah Mark, Thomas F Goss, Doug Malinowski, Stuart J Schnitt, Joseph A Sparano, Michael J Donovan
U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer. Journal of medical economics 27 (1) (2024)
Manasi Datar, William Burchenal, Michael J Donovan, Steven G Coca, Elaine Wang, Thomas F Goss
Payer budget impact of an artificial intelligence in vitro diagnostic to modify diabetic kidney disease progression. Journal of medical economics 24 (1) (2021)